Avidity Biosciences (RNA) is down -19.5%, or -$9.06 to $37.34.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNA:
- Avidity Biosciences: Promising Outlook for DMD Treatment with Del-Zota and Platform Expansion
- Avidity Biosciences price target raised to $56 from $54 at BofA
- Avidity Biosciences
- Avidity Biosciences’ Del-Zota Shows Promising Data in DMD, Justifying Buy Rating and $56 Price Target
- Closing Bell Movers: Opendoor up 36% after management reshuffle